CGRP RECEPTOR ANTAGONISTS

wherein R1, R2 and R3 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Saved in:
Bibliographic Details
Main Authors BUCKNELL, Sarah Joanne, PICKWORTH, Mark, DEFLORIAN, Francesca, CHRISTOPHER, John Andrew, CONGREVE, Miles Stuart, MASON, Jonathan Stephen
Format Patent
LanguageEnglish
French
German
Published 06.03.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:wherein R1, R2 and R3 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Bibliography:Application Number: EP20160791444